The Immunopathogenesis of Familial Transverse Myelitis Due to Mutations in VPS37a
VPS37a 突变引起的家族性横贯性脊髓炎的免疫发病机制
基本信息
- 批准号:10658427
- 负责人:
- 金额:$ 41.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectAgeAge DistributionAmericanAntigensAutophagocytosisBiological MarkersBladder DysfunctionCell Culture TechniquesCellsCentral Nervous SystemCirculationClinicalClustered Regularly Interspaced Short Palindromic RepeatsCommunicationComplexDNADNA Sequence AlterationDiseaseEndosomesFamilyFutureGenesGeneticGenetic ModelsGoalsHumanImageImmuneImmune responseImmune signalingImmune systemImmunosuppressionIncidenceInflammatoryIntegral Membrane ProteinIntestinesLinkLipidsLymphocyteMass Spectrum AnalysisMediatingMedicalMembrane ProteinsModalityMolecular MimicryMultivesicular BodyMutationNervous SystemNervous System PhysiologyNeurologicNeuronsNumbnessParalysedPathogenesisPathway interactionsPatientsPeptide Sequence DeterminationPeripheralPersonsPolishesPopulationPredispositionPrevalenceProductionProteinsRNARecording of previous eventsRecyclingResearchRiskRisk FactorsRoleSerologySignal PathwaySisterSortingSpinal CordSystemSystemic infectionTeenagersTestingTimeTransverse MyelitisVacuolar Protein SortingVariantVesicleWomanWorkautoimmune pathogenesisbiobankdisabilityexome sequencingexosomeexperimental studyextracellular vesiclesgenetic variantgranulocyteinsightmenmetermonocyteneuron componentnovel therapeuticsosteosarcomatreatment response
项目摘要
PROJECT SUMMARY
Idiopathic transverse myelitis (ITM) is a single autoimmune attack on the spinal cord that leads to weakness,
numbness, and bowel/bladder dysfunction. The incidence is approximately 1-2 per million per year with a
prevalence of approximately 7,500 Americans living with disability from their ITM today. There is are two peak
age distributions with onsets in the teenage years and in adulthood. Men and women are equally affected.
Treatment involves immunosuppression at the time of the attack but neurologic disability persists in greater
than two thirds of cases.
ITM is conventionally viewed as a sporadic disease, with no strong familial risk factors and no recognized
genetic contribution to risk. Recently, we encountered a family of Polish origin with two sisters affected by ITM,
one presenting at age 15 and one presenting at age 50. This unusual occurrence prompted us to seek a
genetic basis for ITM. Genetic sequencing of these sisters revealed that they both harbor a very rare mutation
in a gene called Vacuolar Protein Sorting-Associated Protein 37A (VPS37A). VPS37A is a component of the
endosomal sorting complex required for transport I (ESCRT-1) complex, which is involved in recycling proteins.
This genetic mutation is exceedingly rare in human populations, but among a group 86 ITM patients we
discovered a third patient of Irish/Scottish origin who harbored the same VPS37A genetic mutation. Our results
strongly implicate VPS37A in the cause of ITM and suggest that familial forms of ITM has a genetic
component.
The goals of this proposal are to understand how a genetic mutation in VPS37A causes ITM. Specifically, we
will focus on how this genetic mutation leads to a predisposition to develop an immune mediated attack of the
spinal cord.
项目概要
特发性横贯性脊髓炎 (ITM) 是一种针对脊髓的单一自身免疫性攻击,会导致无力、
麻木和肠/膀胱功能障碍。每年发病率约为百万分之 1-2
目前,大约 7,500 名美国人患有 ITM 残疾。有两个峰值
发病年龄分布在青少年时期和成年期。男性和女性同样受到影响。
治疗包括在发作时进行免疫抑制,但神经功能障碍在更大范围内持续存在
超过三分之二的案例。
ITM 通常被认为是一种散发性疾病,没有强烈的家族危险因素,也没有得到公认
遗传对风险的贡献。最近,我们遇到一个波兰裔家庭,有两个姐妹受到ITM影响,
一名在 15 岁时就诊,一名在 50 岁时就诊。这种不寻常的现象促使我们寻找一种
ITM 的遗传基础。这些姐妹的基因测序显示她们都携带一种非常罕见的突变
位于称为液泡蛋白分选相关蛋白 37A (VPS37A) 的基因中。 VPS37A 是一个组件
转运 I (ESCRT-1) 复合物所需的内体分选复合物,该复合物参与蛋白质的回收。
这种基因突变在人群中极其罕见,但在 86 名 ITM 患者中,我们发现
发现了第三名爱尔兰/苏格兰血统的患者,其携带相同的 VPS37A 基因突变。我们的成果
强烈暗示 VPS37A 与 ITM 的病因有关,并表明 ITM 的家族形式具有遗传性
成分。
该提案的目标是了解 VPS37A 的基因突变如何导致 ITM。具体来说,我们
将重点关注这种基因突变如何导致对免疫介导的攻击产生倾向
脊髓。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Levy其他文献
Michael Levy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Levy', 18)}}的其他基金
Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica
利用基于新 T 细胞的视神经脊髓炎小鼠模型开发耐受疗法
- 批准号:
10396470 - 财政年份:2018
- 资助金额:
$ 41.75万 - 项目类别:
Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica
利用基于新 T 细胞的视神经脊髓炎小鼠模型开发耐受疗法
- 批准号:
9919500 - 财政年份:2018
- 资助金额:
$ 41.75万 - 项目类别:
immunopathogenesis of NMO-IgG and AQP4-specific T cells in neuromyelitis optica
NMO-IgG 和 AQP4 特异性 T 细胞在视神经脊髓炎中的免疫发病机制
- 批准号:
8653032 - 财政年份:2013
- 资助金额:
$ 41.75万 - 项目类别:
immunopathogenesis of NMO-IgG and AQP4-specific T cells in neuromyelitis optica
NMO-IgG 和 AQP4 特异性 T 细胞在视神经脊髓炎中的免疫发病机制
- 批准号:
8509867 - 财政年份:2013
- 资助金额:
$ 41.75万 - 项目类别:
immunopathogenesis of NMO-IgG and AQP4-specific T cells in neuromyelitis optica
NMO-IgG 和 AQP4 特异性 T 细胞在视神经脊髓炎中的免疫发病机制
- 批准号:
9262280 - 财政年份:2013
- 资助金额:
$ 41.75万 - 项目类别:
immunopathogenesis of NMO-IgG and AQP4-specific T cells in neuromyelitis optica
NMO-IgG 和 AQP4 特异性 T 细胞在视神经脊髓炎中的免疫发病机制
- 批准号:
8845267 - 财政年份:2013
- 资助金额:
$ 41.75万 - 项目类别:
Expansion and Enhancement of our Juvenile Drug Court
扩大和加强我们的青少年毒品法庭
- 批准号:
7419375 - 财政年份:2006
- 资助金额:
$ 41.75万 - 项目类别:
Expansion and Enhancement of our Juvenile Drug Court
扩大和加强我们的青少年毒品法庭
- 批准号:
7447833 - 财政年份:2006
- 资助金额:
$ 41.75万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 41.75万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 41.75万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 41.75万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 41.75万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 41.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 41.75万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 41.75万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 41.75万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 41.75万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 41.75万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




